Transcript Agenda - National Immunoglobulin Database

Immunoglobulin Demand
Management
Trust Database Training
MAY 2008
Objectives of training - aimed at data entry staff
• High level understanding of the need for the IVIg programme
• Identify the key stakeholders in the programme
• Understand how to use the key functions of the database
• Understand your role in updating the database
• Establish who will support you going forward and how to get help
• Answer your questions
http://www.intravenousimmunoglobulin.org/
2
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
3
The DH kicked off the IVIg Demand management
programme in 2006 to meet a number of historic challenges
•DEMAND MANAGEMENT OF IMMUNOGLOBULINS
Demand
Management
Plan
(promotion
of
alternatives)
Clinical
Guidelines
for
appropriate
use of
IVIg
Development
of
database
Model
Commissioning
Policy (MCP)
Alternatives
This programme aims to ensure that critical patients receive
product and improve consistency of use of immunoglobulin
Plan
online
Guidelines
online
http://www.intravenousimmunoglobulin.org/
Database
online
4
MCP
document
Alternatives
document
The National database will keep us informed on IVIg use
The purpose of the National Database is to:
• Support the data management and reporting requirements of the Demand Management
Plan nationally agreed following extensive consultation with a wide range of stakeholders
• Capture immunoglobulin data from trusts nationally
• Inform a model of UK immunoglobulin use (along with PASA checking Pharmex)
• Enable better forecasting of likely use once the data history and quality builds up
• Estimate the requirements for alternatives to immunoglobulin such as plasma exchange
• Inform research and enable clinical trials regarding efficacy of immunoglobulin therapy
• Enable the formation of better contracts with immunoglobulin manufacturers
• Enable batch tracking
Data Collection Exercise
Pilot Sites Helped Development
• Oxford Radcliff (Jenny Dorey)
• Short term data collection
• Enabled better understanding of what
the database should capture and effort
• Use Pilot sites to support the exercise
• Data in live system
• Available to trusts who entered it
• NLAG (Carrock Sewell)
• GKT (Stuart Richardson)
• UCLH (Evelyn Frank)
• Southend (Kevan Wind)
http://www.intravenousimmunoglobulin.org/
5
The IVIg database has a simple technical architecture that
requires no end-user software and minimal training
Database Overview
DH and Trusts
NHS
MDSAS
Portal/Web
Team
Technical
Support
Reporting & Analysis
MS
Internet
Explorer
only
Dendrite
Propriety
Solution
• Dendrite developed the solution and will
host it: keeping it up and running
• Anonymised data is owned by the DH
• NHS MDSAS will manage the vendor
and end user support
• Database security - ID & password
controlled entry managed by Trusts
Data Management
Dendrite
Propriety
Solution
Developers
• DH commissioned National database for
patients undergoing immunoglobulin
therapy in the UK
• Efforts to align with national
standards have been successful
CfH
• Over the course of the next year,
database will improve in terms of
usage, data completeness and quality
• Increased automation, including bar
coding, for the database is being
planned
Data Validation
Outputs (To be confirmed by MDSAS):
• Monthly reports including compliance
will be delivered
Data Entry
• Ad hoc data analysis
• Annual reports
Users
http://www.intravenousimmunoglobulin.org/
6
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
7
Database entry is based on a simple process
Panel
Decision
Registration
•
•
•
•
Demographics
Alternatives
Indication
Dose detail
• Approval
• Efficacy
Tracking
Infusion
Details
•
•
•
•
Prescriptions
Product detail
Returns
Infusion
Summary
Follow-up
• Follow-up
• Efficacy
Tracking
• Update
Registration
• Simple process based on paper-based form to track IVIg usage
• Different roles required to fill different parts of the form
• Responsibility of Trusts to assign responsibilities and process of
getting the data into the database
• Some trusts are using data entry teams to manage data entry
• Further information on the process by reading the Demand
Management Plan, Clinical Guidelines and Model Commissioning
Policy, available on the website
http://www.intravenousimmunoglobulin.org/
8
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
9
1. Logging In
Login Screen
http://www.intravenousimmunoglobulin.org/
10
1. Logging In
Welcome Screen
http://www.intravenousimmunoglobulin.org/
11
1. Logging In
Export Data
http://www.intravenousimmunoglobulin.org/
12
1. Logging In
Enter Clinical Data
http://www.intravenousimmunoglobulin.org/
13
2. Registration
Registration Data
http://www.intravenousimmunoglobulin.org/
14
2. Registration
Alternatives
http://www.intravenousimmunoglobulin.org/
15
2. Registration
Indication & Dose Information
http://www.intravenousimmunoglobulin.org/
16
2. Registration
Diagnosis
http://www.intravenousimmunoglobulin.org/
17
2. Registration
Diagnosis
http://www.intravenousimmunoglobulin.org/
18
2. Registration
Indication & Dose Information
http://www.intravenousimmunoglobulin.org/
19
Patient Listing
http://www.intravenousimmunoglobulin.org/
20
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
21
3. Panel
Panel Information
http://www.intravenousimmunoglobulin.org/
22
4. Infusion
Prescription Details
http://www.intravenousimmunoglobulin.org/
23
4. Infusion
Prescription Returns
http://www.intravenousimmunoglobulin.org/
24
4. Infusion
Summary
http://www.intravenousimmunoglobulin.org/
25
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
26
5. Follow-up
Follow-up Details
http://www.intravenousimmunoglobulin.org/
27
5. Follow-up
Update Registration
http://www.intravenousimmunoglobulin.org/
28
Patient Listing
http://www.intravenousimmunoglobulin.org/
29
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
30
There are a number of support options – try website first
Lost / Forgotten Passwords?
Database
Users
Local Internet Access Issues?
All other queries
should be logged
with MDSAS first
Local Trust
IT
Dendrite
MDSAS
The website
will contain:
• Demand Management Plan and Clinical Guidelines
• Frequently Asked Questions for Programme and Database
• IVIg Database Detailed Reference Guide
• Link to the database and training materials
http://www.intravenousimmunoglobulin.org/
31
Agenda
• IVIg Introduction and Background
• Proposed Process Overview
• Database Login and Registration Demo
• Database Panel and Infusion Demo
• Database Follow Up Demo
• End User Support Options
• Questions
http://www.intravenousimmunoglobulin.org/
32
Did we meet our Objectives?
• High level understanding of the need for the IVIg programme:
– Address problems with supply of IVIg and Demand Management
– Database to inform on IVIg usage and enable tracking and forecasting
• Identify the key stakeholders in the programme:
– Department of Health sponsor and own the programme
– NHS MDSAS will support the end user community
• Understand how to use the key functions of the database:
– Easy to use database as demonstrated
– Training materials available on the internet
• Understand your role in updating the database:
– Data entry and filling in the required forms
• Establish who will support you going forward and how to get help:
– NHS MDSAS will support the end user community
• Answer your questions
http://www.intravenousimmunoglobulin.org/
33